THERATECHNOLOGIES INC. - and - INVESTISSEMENT QUÉBEC INVESTOR RIGHTS AGREEMENT October 31, 2023Investor Rights Agreement • November 6th, 2023 • Theratechnologies Inc. • Pharmaceutical preparations
WHEREAS a subscription agreement was entered into between the Investor and the Corporation pursuant to which the Investor purchased from the Corporation (i) 9,118,184 common shares in the share capital of the Corporation (the “Subscribed Shares”), representing approximately 19.9% of the issued and outstanding common shares in the share capital of the Corporation; and (ii) 3,381,816 subscription receipts (the “Subscription Receipts”) exchangeable, in accordance with the terms and conditions of the exchangeable receipt agreement entered into between the Investor and the Corporation on the date hereof, for common shares of the share capital of the Corporation on a one-for-one basis (the “Underlying Shares”), all of the issuable Underlying Shares representing, together with the Subscribed Shares, approximately 25.4% of the issued and outstanding common shares in the share capital of the Corporation; and
